Cambridge Investment Research Advisors, Inc. Amarin Corp Plcuk Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 22,142 shares of AMRN stock, worth $10,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,142
Previous 20,592
7.53%
Holding current value
$10,849
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AMRN
# of Institutions
177Shares Held
65.1MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$12.2 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$6.08 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.62 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.25 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.23 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $198M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...